Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gemedica is a Czech pharmaceutical company specializing in the registration, marketing, and distribution of generic and specialty medicinal products. Founded in 2004 and headquartered in Prague, the company focuses on providing high-quality pharmaceutical solutions across several key therapeutic areas, including cardiology, neurology, psychiatry, and oncology. Gemedica operates primarily within the Central European market, where it manages a diverse portfolio of branded generics and acts as a local representative for international pharmaceutical manufacturers. The company's business model is centered on ensuring the availability of essential medications through strategic partnerships and efficient commercialization of proven therapeutic molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gemedica.